long term side effects of glp 1 drugs glp-1 GLP-1 medications, commonly used for type 2 diabetes What are experts learning about
Description
And a snowballing number of additional companies are trying to develop even more powerful drugs
A recent study of a clinical trial of 483 adults found that nearly 18% did not respond to the drugs
These numbers should be interpreted cautiously given the different trial designs, but the trend is consistent across multiple analyses
Like many providers who prescribe GLP-1s, Yuval Pinto, MD, has worked with select patients to gradually reduce how often they take the medication
A fatal adverse reaction occurred in 1 patient treated with REBLOZYL who died due to an unconfirmed case of acute myeloid leukemia (AML)
Data were normalized to maximum concentrations of GLP-1 or GIP (100%) and no ligand (0%) and analyzed by nonlinear regression (sigmoidal concentration-response) and plotted using GraphPad Prism 7 software
